Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2017; 42(2): 212-215


A clinicopathological study of idiopathic granulomatous mastitis

Fareeha Farooqui, Humera Naz Altaaf, Samia Nawaz Dar, Maryyam Asif, Mina’a Shahid, Muhammad Amir.




Abstract

Objective: To see the clinical presentation, management and recurrence in our patients of Idiopathic granulomatous mastitis (IGM).
Methodology: This cross-sectional study was conducted from 2008 to 2015 at Shifa International Hospital, Islamabad, Pakistan and included all cases of IGM. Chart review and telephonic follow up was done and sign, symptom, treatment given and recurrence at one year were recorded. Results were analyzed using SPSS Version 16.
Results: Total number of patients seen during the study period was 44. Mean age was 34.227±5.093 years. All presented with a unilateral disease, 36(81.8%) had a painful lump, 7(15.9%) with lump and skin changes and one(2.3%) case had a discharging sinus. 14 (31.8%) cases underwent incision and drainage, 30 (68.2%) had excision biopsy. Steroids were given in 17(38.6%) cases. Recurrence was seen in 3 (6.8%) cases.
Conclusion: Granulomatous lobular mastitis is a rare, benign breast disease of reproductive age group. Increased awareness will improve the understanding as well as its management

Key words: Breast lump, idiopathic granulomatous mastitis, lumpectomy, steroids.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.